134 related articles for article (PubMed ID: 37220222)
1. Orbital Radioiodine Uptake in Epithelial Conjunctival Inclusion Cyst on Scintigraphy in a Patient With Differentiated Thyroid Cancer.
Makarewicz M; Skierkowski W; Makarewicz J
Clin Nucl Med; 2023 Aug; 48(8):e382-e384. PubMed ID: 37220222
[TBL] [Abstract][Full Text] [Related]
2. Differentiated thyroid cancer: Case report of false positive
Giannoula E; Koutsouki G; Exadaktylou P; Papadopoulos N; Papanastasiou E; Doumas A; Iakovou I
Hell J Nucl Med; 2023; 26(1):66-69. PubMed ID: 37031423
[TBL] [Abstract][Full Text] [Related]
3. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
4. Orbital Radioiodine Uptake on Scintigraphy in a Patient with Thyroid Cancer.
García-Moreno RM; Escabias C; Utrilla C; Ruiz-Bravo E; Sánchez M; Lecumberri B
Eur Thyroid J; 2019 Jul; 8(4):221-224. PubMed ID: 31602366
[TBL] [Abstract][Full Text] [Related]
5. False-positive radioiodine whole-body scan due to a renal cyst.
Maciejewski A; Czepczyński R; Ruchała M
Endokrynol Pol; 2018; 69(6):736-739. PubMed ID: 30306537
[TBL] [Abstract][Full Text] [Related]
6. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer.
Campennì A; Violi MA; Ruggeri RM; Sindoni A; Moleti M; Vermiglio F; Baldari S
Nucl Med Commun; 2010 Apr; 31(4):274-9. PubMed ID: 20087239
[TBL] [Abstract][Full Text] [Related]
8. Beard Contamination With 131I Diagnosed by SPECT/CT in a Patient With Differentiated Thyroid Cancer.
Makarewicz J; Rudzki J
Clin Nucl Med; 2024 May; ():. PubMed ID: 38768062
[TBL] [Abstract][Full Text] [Related]
9.
Giovanella L; Paone G; Ruberto T; Ceriani L; Trimboli P
Endocrinol Metab (Seoul); 2019 Mar; 34(1):63-69. PubMed ID: 30784242
[TBL] [Abstract][Full Text] [Related]
10. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
[TBL] [Abstract][Full Text] [Related]
11. Combined BRAF
Campennì A; Ruggeri RM; Siracusa M; Pignata SA; Di Mauro F; Vento A; Trimarchi F; Baldari S
J Endocrinol Invest; 2018 Nov; 41(11):1283-1288. PubMed ID: 29549631
[TBL] [Abstract][Full Text] [Related]
12. Focal thoracic uptake mimicking lung metastasis on 131I post-therapy whole-body scan in patients with thyroid carcinoma.
Jia C; Moadel R; Freeman LM
Clin Nucl Med; 2014 Apr; 39(4):360-2. PubMed ID: 24598344
[TBL] [Abstract][Full Text] [Related]
13. Unexpected radioactive iodine accumulation on whole-body scan after I-131 ablation therapy for differentiated thyroid cancer.
Iwano S; Ito S; Kamiya S; Ito R; Kato K; Naganawa S
Nagoya J Med Sci; 2020 May; 82(2):205-215. PubMed ID: 32581401
[TBL] [Abstract][Full Text] [Related]
14. Association between residual thyroid carcinoma and diffuse hepatic uptake of 131I following radioiodine ablation in postoperative total thyroidectomy patients.
Tatar FA; Morita E; Ituarte PH; Cavalieri RR; Duh QY; Price DC; Siperstein AE; Clark OH
World J Surg; 2001 Jun; 25(6):718-22. PubMed ID: 11376405
[TBL] [Abstract][Full Text] [Related]
15. The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer.
Van Nostrand D; Aiken M; Atkins F; Moreau S; Garcia C; Acio E; Burman K; Wartofsky L
Thyroid; 2009 Aug; 19(8):849-55. PubMed ID: 19281428
[TBL] [Abstract][Full Text] [Related]
16. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
Carril JM; Quirce R; Serrano J; Banzo I; Jiménez-Bonilla JF; Tabuenca O; Barquín RG
J Nucl Med; 1997 May; 38(5):686-92. PubMed ID: 9170428
[TBL] [Abstract][Full Text] [Related]
17. Hepatic metastasis of differentiated thyroid carcinoma.
Kraft O
Nucl Med Rev Cent East Eur; 2005; 8(1):44-6. PubMed ID: 15977146
[TBL] [Abstract][Full Text] [Related]
18. [Ovarian endometriosis cyst with iodine 131 uptake : first case of false positive in the follow up for differentiated thyroid carcinoma].
Lungo M; Tenenbaum F; Chaumerliac P; Vons C; Mirat A; Beuzen F; Luton JP; Richard B
Ann Endocrinol (Paris); 2000 May; 61(2):147-50. PubMed ID: 10891665
[TBL] [Abstract][Full Text] [Related]
19. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
20. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]